Trial intelligence / Profile preview

Pre-emptive Hydromorphone for Rebound Pain After Rotator Cuff Repair

NCT02939209Phase 4Completed

Start
Apr 2017
Primary completion
May 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Hydromorphone with Placebo (2 arms). Primary endpoint: Worst pain score at 24 hours. Started Apr 2017; status: completed.

02

Drugs

hydromorphone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02939209.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02939209.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call